[New cytostatics in the therapy of non-small cell bronchial carcinoma].
作者信息
Serke M, Schönfeld N, Loddenkemper R
机构信息
Lungenklinik Heckeshorn, Berlin.
出版信息
Pneumologie. 1998 Jun;52(6):333-7.
PMID:9715648
Abstract
摘要
相似文献
1
[New cytostatics in the therapy of non-small cell bronchial carcinoma].
Pneumologie. 1998 Jun;52(6):333-7.
2
Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.紫杉醇、多西他赛、吉西他滨和长春瑞滨治疗非小细胞肺癌的临床疗效及成本效益：一项系统评价
Thorax. 2002 Jan;57(1):20-8. doi: 10.1136/thorax.57.1.20.
3
[Maintenance chemotherapy in advanced NSCLC].[晚期非小细胞肺癌的维持化疗]
Rev Pneumol Clin. 2006 Feb;62 Spec no 1:1S16-8.
4
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy].[非小细胞肺癌同步放化疗：迈向理想策略]
Rev Mal Respir. 2001 Sep;18(4 Pt 1):365-6.
5
Promising new agents in the treatment of non-small cell lung cancer.
Cancer Chemother Pharmacol. 1996;37(5):385-93. doi: 10.1007/s002800050402.
6
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.吉西他滨联合紫杉醇或长春瑞滨与单独使用紫杉醇或吉西他滨治疗老年或身体状况不佳的晚期非小细胞肺癌患者的比较。
Br J Cancer. 2004 Aug 2;91(3):489-97. doi: 10.1038/sj.bjc.6602011.
7
[New wave of chemotherapeutic agents: update in pulmonary oncology].
Rev Mal Respir. 1997 Apr;14(2):154-6.
8
Rationale for non-platinum chemotherapy in advanced NSCLC.晚期非小细胞肺癌非铂类化疗的理论依据。
Oncology (Williston Park). 2001 Jul;15(7 Suppl 8):29-34.
9
New chemotherapeutic agents for non-small cell lung cancer.
Chest. 1995 Jun;107(6 Suppl):306S-311S. doi: 10.1378/chest.107.6_supplement.306s.
Zotero 插件